Implication of CD35, CD21 and CD55 in Exudative Age-related Macular Degeneration

Rudolf Foundation Clinic120 enrolled

Overview

The purpose of this study is to determine a possible implication of CD21, CD35 and CD55 in the pathogenesis of age-related macular degeneration. The aim is to asses a difference in expression rates of these factors on AMD-patients and a healthy control group.

Study Type

OBSERVATIONAL

Enrollment

120

Conditions

Age-Related Macular Degeneration

Interventions

cd 35, cd21, cd55OTHER

Blood drawing/ 10ml/ once- duration of 1 day of full examination of the patient

Eligibility

Sex: ALLMin age: 55 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Man and women over 18 years old * Filled out informed consent * Diagnosis of non-exudative/ exudative age related macular degeneneration Exclusion Criteria: * Inherited retinal diseases * Other acquired retinal/ macular * Missing informed consent

Locations (1)

Rudolf Foundation Clinic

Vienna, State of Vienna, Austria

Outcomes

Primary Outcomes

determine a possible implication of CD21, CD35 and CD55 in the pathogenesis of age-related macular degeneration

Time frame: 1 day

Secondary Outcomes

expression rates of on AMD-patients and a healthy control group

Time frame: 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.